Hallmarks such as E2F Targets, G2M Checkpoint, and TNFα Signaling are upregulated, while Myogenesis and Adipogenesis are downregulated, highlighting the aggressive nature of ESCC and potential suppression of differentiation pathways. The gene discussed is TNF; the disease is esophageal squamous cell carcinoma.